SCHEMBL7082301

SCHEMBL7082301

Cn1cccc1C(=NO)c1ccc(Nc2ccccc2N)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 11/20 0.51
MAPK13 O15264 10/20 0.51
MAPK12 P53778 10/20 0.51
MAPK11 Q15759 10/20 0.51
SMN1; SMN2 Q16637 4/20 0.39
HSD17B10 Q99714 2/20 0.39
MAPT P10636 5/20 0.37
GAA P10253 3/20 0.37
TDP1 Q9NUW8 2/20 0.37
GRM1 Q13255 1/20 0.36
KDM4E B2RXH2 3/20 0.36
TP53 P04637 1/20 0.36
APP P05067 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
SNCA P37840 1/20 0.36
BLM P54132 1/20 0.36
MAP2K2 P36507 1/20 0.35
MAP2K1 Q02750 1/20 0.35
MEN1 O00255 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7082298 1.00 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7076418 0.88 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7076419 0.88 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7080033 0.84 MAPK14 (0.65) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7080336 0.84 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7075166 0.83 MAPK13 (0.56) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7075172 0.83 MAPK13 (0.56) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7079620 0.82 MAPK14 (0.48) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7079618 0.82 MAPK14 (0.48) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7076531 0.76 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MAPK14 28/4885MAPK13 33/4885MAPK12 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.